XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 1,714 $ 21
Receivables, net of allowance for credit losses of $117 and $237, respectively 17,272 15,638
Contract asset 10,745 10,091
Inventories, net 6,230 4,547
Refundable income taxes 13 84
Prepaid expenses and other current assets 2,382 1,545
Current assets held for sale 15,967 9,548
Total current assets 54,323 41,474
Property, plant and equipment, net 26,261 29,467
Operating lease right-of-use assets, net 13,326 14,221
Goodwill 3,493 3,493
Other assets 357 368
Noncurrent assets held for sale 6,864 7,258
Total assets 104,624 96,281
Current liabilities:    
Current maturities of long-term debt 353 374
Promissory note — related party 3,510 0
Revolver 20,142 16,289
Short-term operating lease liabilities 879 818
Accounts payable 11,574 11,024
Contract liabilities 2,879 731
Accrued liabilities (related party — $880 and nil, respectively) 4,615 3,342
Current liabilities held for sale 10,058 8,661
Total current liabilities 54,010 41,239
Long-term operating lease liabilities, net of short-term 13,035 13,915
Deferred income taxes, net 154 142
Pension liability 2,465 3,105
Other long-term liabilities 645 661
Noncurrent liabilities held for sale 3,890 2,884
Shareholders’ equity:    
Serial preferred shares, no par value, authorized 1,000 shares; 0 shares issued and outstanding at September 30, 2024 and 2023 0 0
Common shares, par value $1 per share, authorized 10,000 shares; issued and outstanding shares 6,158 at September 30, 2024 and 6,105 at September 30, 2023 6,158 6,105
Additional paid-in capital 11,775 11,626
Retained earnings 17,881 23,264
Accumulated other comprehensive loss (5,389) (6,660)
Total shareholders’ equity 30,425 34,335
Total liabilities and shareholders’ equity $ 104,624 $ 96,281